Necrobacillosis in humans

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 2, 2011, Pages 227-236

  Dahlén, Gunnar ^a   Ebenfelt, Anders ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fusobacterium necrophorum; Lemierre's syndrome; necrobacillosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CLINDAMYCIN; DALTEPARIN; METRONIDAZOLE; PENICILLIN G;

BACTERIOLOGY; BACTERIUM IDENTIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CULTURE TECHNIQUE; EMBOLISM; HUMAN; LEMIERRE SYNDROME; MOLECULAR DIAGNOSIS; NECROTIC TONSILLITIS; NONHUMAN; PATHOGENESIS; PERITONSILLAR ABSCESS; REVIEW; STOMATITIS; THROMBOSIS; TONSILLITIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NECROPHORUM; HUMANS; INFANT; LEMIERRE SYNDROME; MALE; MIDDLE AGED; NOMA; PERITONSILLAR ABSCESS; TONSILLITIS; YOUNG ADULT;

EID: 79952164252     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.172     Document Type: Review

References (91)

1. Riordan T. Human infection with Fusobacterium necrophorum (necrobacillosis), with focus on Lemierre's syndrome. Clin. Microbiol. Rev. 20, 622-659 (2007). •• Comprehensive review of necrobacillosis.
2. Brazier JS. Human infections with Fusobacterium necrophorum. Anaerobe 12, 165-172 (2006). •• Comprehensive review on Fusobacterium necrophorum infection in humans.
3. Huggan PJ, Murdoch DR. Fusospirochetal infections: clinical spectrum and incidence of invasive disease. J. Infect. 57, 283-289 (2008). • Important paper on fusospirochetal infections in humans.
4. Alston JM. Necrobacillosis in Great Britain. Br. Med. J. 1524-1528 (1955).
5. Moore-Gillon J, Lee TH, Eykyn SJ, Philips I. Necrobacillosis: a forgotten disease. Br. Med. J. 288, 1526-1527 (1984).
6. Eykyn SJ. Necrobacillosis. Scand. J. Infect. Dis. 62(Suppl.), 41-46 (1989).
7. Hagelskjaer Kristensen L, Prag J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical study. Eur. J. Clin. Microbiol. Dis. 27, 779-789 (2008). •• Comprehensive clinical and microbiological study of F. necrophorum infections.
8. Hagelskjaer Kristensen L, Prag J. Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study. Eur. J. Clin. Microbiol. Infect. Dis. 27, 733-739 (2008). • Important study of F. necrophorum infections.
9. Karkos PD, Asrani S, Karkos CD et al. Lemierrés syndrome: a systematic review. Lanryngoscope 119, 1552-1559 (2009). •• Systematic review of case reports and case series from 1950 to 2007.
10. Jones JW, Riordan T, Morgan MS. Investigation of postsanginal sepsis and Lemierre's syndrome in South West peninsula. Comm. Dis. Pub. Health 4, 278-282 (2001).
11. Stjernquist-Desatnik A, Orrling A. Pharyngotonsillitis. Periodontology 2000 49, 140-150 (2009).
12. Brook I. Anaerobic bacteria in upper respiratory tract and other head and neck infections. Ann. Otol. Rhinol. Laryngol. 111, 430-440 (2002).
13. Batty A, Wren MW, Gal M. Fusobacterium necrophorum as the cause of recurrent sore throat comparison of isolates from persistent sore throat syndrome and Lemierre's disease. J. Infect. 51, 299-306 (2005).
14. Rusan M, Klug TE, Ovesen T. An overview of the microbiology of acute ear, nose, and throat infection requiring hospitalization. Eur. J. Clin. Microbiol. Infect. Dis. 28, 241-251 (2009). • Important study of severe upper respiratory infection.
15. Flodström A, Hallander HO. Microbiological aspects on peritonsillar abscesses. Scand J. Infect. Dis. 8, 157-160 (1976).
16. Brook I, Frazier EH, Thompson DH. Aerobic and anaerobic microbiology in patients with peritonsillar abscess. Laryngoscope 101, 289-292 (1991).
17. Brook I. Non-odontogenic abscesses in the head and neck region. Periodontology 2000 49, 106-125 (2009).
18. Jousimies-Somer HR, Savolainen H, Mäkitie A, Ylikoski J. Bacteriologic findings in peritonsillar abscesses in young adults. Clin. Infect. Dis. 16(Suppl. 4), S292-S298 (1993).
19. Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann. Intern. Med. 151, 812-815 (2010). • Paper linking pharyngitis with severe and complicated infections in the head and neck region.
20. Centor RM, Geiger P, Waites KB. Fusobacterium necrophorum bacteremic tonsillitis: 2 cases and a review of the literature. Anaerobe DOI: 10.1016/j. anaerobe.2010.08.005 (2010) (Epub ahead of print).
21. Oteo J, Aracil B, Barros C, Alós JI, Gómez-Garcés JL. Bacteremic pharyngotonsillitis by Fusobacterium necrophorum: a prelude to Lemierre's syndrome. Clin. Microbiol. Newsl. 21, 126-128 (1999). • Paper on the prevalence of F. necrophorum in throat infections.
22. Batty A, Wren MWD. Prevalence of Fusobacterium necrophorum and upper respiratory pathogens isolated from throat swabs. Br. J. Biomed. Sci. 62, 66-70 (2005).
23. Le Monnier A, Jamel A, Carbonelle E et al. Fusobacteriun necrophorum middle ear infection in children and related complications: report of 25 cases and literature. Pedriatr. Infect. Dis. J. 27, 613-617 (2008).
24. Escalona IJ, Carandell AD, Centenero S A-H et al. Lemierre's syndrome associated with dental infections. Report of one case and review of the literature. Med. Oral Patol. Oral Cir. Bucal. 12, 394-396 (2007).
25. Rosado P, Gallego L, Junquera L, de Vicente JC. Lemierre's syndrome: a serious complication of an odontogenic infection. Med. Oral Patol. Oral Cir. Bucal. 14, 398-401 (2009).
26. Enwonwu CO, Falker WA Jr, Philips RS. Noma (Cancrum oris). Lancet 368, 147-156 (2006). •• Comprehensive review on noma (cancrum oris).
27. Enwonwu CO. Epidemiological and biochemical studies of necrotizing ulcerative gingivitis and noma (cancrum oris) in Nigerian children. Arch. Oral Biol. 17, 1357-1371 (1972).
28. Falkler WA Jr, Enwonwu CO, Idigbe EO. Microbiological understandings and mysterics of noma (cancrum oris). Oral Dis. 5, 150-155 (1999).
29. Falkler WA Jr, Enwonwu CO, Idigbe EO. Isolation of Fusobacterium necrophorum from cancrum oris (noma). Am. J. Trop. Med. Hyg. 60, 150-156 (1999).
30. Falkler WA, Enwonwu CO, Ewell AJ, Idigbe EO. Isolation of fusobacteria from the oral cavities of malnourished Nigerian children living in agricultural and herding villages. Oral Dis. 6, 103-105 (2000).
31. Smith GR, Thornton EA. Pathogenicity of Fusobacterium necrophorum strains from man and animals. Epidemiol. Infect. 110, 499-506 (1993).
32. Paster BHJ, Falkler WA, Enwonwu CO et al. Prevalent bacterial species and novel phylotypes in advanced noma lesions. J. Clin. Microbiol. 40, 2187-2191 (2002).
33. Chidzonga MM, Mahomva L. Noma (cancrum oris) in human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV and AIDS): clinical experience in Zimbabwe. J. Oral Maxillofac. Surg. 66, 475-485 (2008).
34. Bottone EJ, Lee P. Fusospirochetal superinfection of preexisting oral lesion in patients with acquired immunodeficiency syndrome. Diagn. Microbiol. Infect. Dis. 29, 51-53 (1997).
35. Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis. 9, 317-322 (2003).
36. Rosebury DS. Microorganisms Indigenous to Man. McGraw Hill, New York, USA (1966).
37. Paster BJ, Russell MK, Alpagot T et al. Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Ann. Periodontol. 7, 8-16 (2002).
38. Emslie RD. Cancrum oris. Dent. Practit. Dent. Rec. 13, 481-495 (1963).
39. Sheiham A. An epidemiological survey of acute necrotizing gingivitis in Nigerians. Arch. Oral. Biol. 11, 937-942 (1966).
40. Pindborg JJ, Bhat M, Devanath KR, Narayana HR, Ramachandra S. Occurrence of acute necrotizing gingivitis in South Indian children. J. Periodontol. 37, 14-19 (1966).
41. Malberger E. Acute infectious oral necrosis among children in Gambia, West Africa. J. Periodontol. 2, 154-162 (1967).
42. Guvenc D, Gokbuget AY, Cintan S et al. An atypical form of necrotizing periodontits. J. Periodontol. 80, 1548-1553 (2009).
43. Aliyu SH, Marriott RK, Curran MD et al. Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice. J. Med. Microbiol. 53, 1029-1035 (2004). • F. necrophorum study in tonsillitis using real-time PCR.
44. Jensen JS, Hagelskjaer Kristensen L, Prag J. Detection of Fusobacterium necrophorum subsp fundiliforme in tonsillitis in young adults by real-time PCR. Clin. Microbiol. Infect. 13, 695-701 (2007).
45. Ludlam H, Howard J, Kingston B et al. Epidemiology of pharyngeal carriage of Fusobacterium necrophorum. J. Med. Microbiol. 58, 1264-1265 (2009).
46. Bentley TP, Brennan DF. Lemierre's syndrome: methicillin-resistant Staphylococcus aureus (MRSA) finds a new home. J. Emerg. Med. 37, 131-134 (2009).
47. Bilal M, Cleveland KO, Gelfand MS. Community-acquired methicillin-resistant Staphylococcuas aureus and Lemierre's syndrome. Am. J. Med. Sci. 338, 326-327 (2009).
48. Gokce Ceylan B, Yavuz L, Baydar CL et al. Lemierre's: a case of a rarely isolated microorganism, Staphylococcus aureus. Med. Sci. Monit. 15, CS58-CS61 (2009).
49. Aouad R, Melkane A, Rassi S. Lemierre's syndrome: unusual cause and presentation. Pediatr. Emeg. Care 26, 376-377 (2010).
50. Kadhiravan T, Piramanayagam P, Banga A, Gupta R, Sharma SK. Lemierre's syndrome due to community-acquired meticillin-resistant Staphylococcus aureus infection and presenting orbital cellulites: a case report. J. Med. Case Reports 8, 374 (2008).
51. Shivashankar GH, Murukesh N, Varma MP, Sharif IM, Glynn G. Infection by Panton-Valentine leukocidin-producing Staphylococcus aureus clinically mimicking Lemierre's syndrome. J. Med. Microbiol. 57, 118-120 (2008).
52. Vargiami EG, Farmaki E, Tsaiopoulou D et al. A patient with Lemierre's syndrome. Eur. J. Pediatr. 169, 491-493 (2010).
53. Bomke AK, Steiner S, Podbielski A. Multiple peritonsillar abscesses caused by Arcanobacterium haemolyticum in a young female. Dtsch Med. Wochenschr. 134, 75-78 (2009).
54. Fernandez-Suarez A, Benitez JM, Vidal AM, Iglesias JM. Lemierre's syndrome and septicaemia caused solely by Arcanobacterium haemolyticum in a young spp. competent patient. J. Med. Microbiol. 58, 1645-1648 (2009).
55. Lundblom K, Jung K, Kulin M. Lemierre's syndrome caused by co-infection by Arcanobacterium haemolyticum and Fusobacterium necrophorum. Infection 38, 427-429 (2010).
56. Mackenzie A, Fuite LA, Chan FT et al. Incidence and pathogenicity of Arcanobacterium hemolyticum during a 2-year study in Ottawa. Clin. Infect. Dis. 5, 177-181 (1995).
57. Therriault BL, Daniels LM, Carter YL, Raasch RH. Severe sepsis caused by Arcanobacterium haemolyticum: a case report and review of the literature. Ann. Pharmacother. 42, 1697-1702 (2008).
58. Volante M, Corina L, Contucci AM, Calo L, Artuso A. Arcanobacterium haemolyticum: two case reports. Acta. Otorhin. Ital. 28, 144-146 (2008).
59. Hile LM, Gibbons MD, Hile DC. Lemierre syndrome complicating otitis externa: case report and a literature review. J. Emerg. Med. DOI: 10.1016/j.jemermed.2009.02.014 (2009) (Epub ahead of print).
60. Sharma D, Rouphael N. Case report: atypical Lemierre's disease secondary to Porphyromonas asaccharolytica. Curr. Opin Pediatr. 21, 397-400 (2009).
61. Smith GR, Thornton EA. Classification of human and animal strains of Fusobacterium necrophorum by their pathogenic effects in mice. J. Med. Microbiol. 46, 8769-8882 (1997).
62. Chen Y, Colodner R, Chazan B, Raz R. Pharyngotonsillitis due to Arcanobacterium haemolyticum in northern Istrael. Israel Med. Assoc. J. 7, 241-242 (2005).
63. Falkler WA Jr, Enwonwu CO, Idigbe EO. Oro-facial gangrene (noma/cancrumoris): pathogenic mechanisms. Crit. Rev. Oral Biol. Med. 11, 159-171 (2000).
64. Loesche WJ, Syed SA, Laughon BE, Stoll J. The bacteriology of acute necrotizing ulcerative gingivitis. J. Periodontol. 53, 223-230 (1982).
65. Listgarten MA, Lewis DW. The distribution of spirochetes in the acute necrotizing ulcerative gingivitis: an electron microscopic and statistical survey. J. Periodontol. 38, 379-386 (1967).
66. Listgarten MA, Socransky SS. Ultrastructural characteristics of a spirochete in the lesion of acute necrotizing gingivostomatitis. Arch. Oral. Biol. 9, 95-96 (1964).
67. Seymour GG. Mouth infection and Treponema vincenti. S. Afr. Med. J. 9, 1143-1147 (1957).
68. Wyss C, Dewhirst FE, Gmur R et al. Treponema putidum sp. nov., a mediumsized proteolytic spirochaete of human periodontitis and acute necrotizing ulcerative gingivitis. Int. J. Syst. Evol. Microbiol. 54, 1117-1122 (2004).
69. Dahlén G, Fabricius L, Holm SE, Möller ÅJR. Interactions within a collection of eight bacterial strains isolated from a monkey dental root canal. Oral. Microbiol. 2(Suppl.), 164-170 (1987).
70. Dahlen G. Bacterial infections of the oral mucosa. Periodontology 2000 49, 13-38 (2009).
71. Jensen JS, Hagelskjaer Kristensen L, Nielsen H, Prag J. Minimum requirements for a rapid and reliable routine identification and antibiogram of Fusobacterium necrophorum. Eur. J. Clin. Microbiol. Infect. Dis. 27, 557-563 (2008). •• Comprehesive study of the culture identification of F. necrophorum.
72. Hagelskjaer LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's symdrome in Denmark 1990-1995. Eur. J. Clin. Microbiol. Infect. Dis. 17, 561-565 (1998).
73. Nagano Y, Watabe M, Porter KG et al. Development of a genus-specific PCR assay for the molecular detection, confirmation and identification of Fusobacterium spp. Br. J. Biomed. Sci. 64, 74-77 (2007). • A study on the prevalence of F. necrophorum in tonsillitis and healthy controls using real-time PCR.
74. Nicholson LA, Morrow CJ, Corner LA, Hodgson AL. Phylogenetic relationship of Fusobacterium necrophorum A, AB, and B biotypes based on 16S rRNA gene sequence analysis. Int. J. Syst. Bacteriol. 44, 315-319 (1994).
75. Narongwanichgarn W, Misawa N, Jin JH et al. Specific detection and differentiation of two subspecies of Fusobacterium necrophorum by PCR. Vet. Microbiol. 93, 183-195 (2003).
76. Jensen A, Kristensen LH, Prag J. Fusobacterium necrophorum in young patients with tonsillitis and healthy controls examined by real-time PCR. Clin. Microbiol. Infect. 13, 695-701 (2007).
77. Aliyu SH, Yong PFK, Newport MJ et al. Molecular diagnosis of Fusobacterium necrophorum infection (Lemierre's syndrome). Eur. J. Clin. Microbiol. Infect. Dis. 24, 226-229 (2005).
78. Papapanou PN, Madianos P, Dahlén G, Sandros J. Checkerboard versus culture: a comparison between two methods for identification of subgingival microbiota. Eur. J. Oral Sci. 105, 389-396 (1997).
79. Dahlén G, Leonhardt Å. A new checkerboard panel for testing bacterial markers of periodontitis. Oral. Microbiol. 21(Suppl.), 6-11 (2006).
80. Finegold SM. Anaerobic Bacteria in Human Disease. Academic Press, NY, USA (1977).
81. Narayanan SK, Stewart GC, Chengappa MM et al. Fusobacterium necrophorum leukotoxin induces activation an apoptosis of bovine leukocytes. Infect. Immun. 70, 4609-4620 (2002).
82. Nagaraja TG, Narayanan SK, Stewart GC, Chengappa MM. Fusobacterium necrophorum in animals: pathogesis and pathogenic mechanisms. Anaerobe 11, 239-246 (2005).
83. Tan ZL, Nagaraja TG, Chenggappa MM. Fusobacterium necrophorum infections: virulence factors, pathogenic mechanisms and control measures. Vet. Res. Commun. 20, 113-140 (1996).
84. Narayanan SK, Nagaraja TG, Chengpapa MM, Stewart GC. Cloning and sequencing and expression of the leukotoxin gene from Fusobacterium necrophorum. Infect. Immun. 69, 5447-5455 (2001).
85. Tadepalli S, Stewart GC, Nagaraja TG, Narayanan SK. Human Fusobacterium necrophorum strains have a leukotoxin gene and exhibit leukotoxic activity. J. Med. Microbiol. 57, 225-231 (2008).
86. Zhang F, Nagaraja TG, George D, Stewart GC. The two major subspecies of Fusobacterium necrophorum have distinct leukotoxin operon promoter regions. Vet. Microbiol. 112, 73-78 (2006).
87. Bennett G, Zhou H, Hickford JG. Undetected lktA genes within Fusobacterium necrophorum? J. Med. Microbiol. 59, 499-500 (2010).
88. Oelke AM, Nagaraja TG, Wilkerson MJ, Stewart GC. The leukotoxin operon of Fusobacterium necrophorum is not present in other species of Fusobacterium. Anaerobe 11, 123-129 (2005).
89. Saginala S, Nagaraja TG, Lechtenberg KF, Chengappa MM, Kemp KE, Hine PM. Effect of Fusobacterium necrophorum leukotoxoid vaccine on susceptibility to experimetally induced liver abscesses in cattle. J. Anim. Sci. 75, 1160-1166 (1997).
90. Hoehn KS. Lemierre's syndrome: the controversy of anticoagulation. Pediatrics 115, 1415-1416 (2005).
91. Bondy P. Grant T. Lemierre's syndrome: what are the roles for anticoagulation and the long-term antibiotic therapy. Ann. Otol. Rhinol. Laryngol. 117, 679-683 (2008).